Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Neurobiology of Disease|November 9, 2017
Increased motor neuron resilience by small molecule compounds that regulate IGF-II expressionTeresia M Osborn, Jonathan Beagan, Ole IsacsonFrontiers in Cellular Neuroscience|April 23, 2020
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease PatientsTeresia M Osborn, Penelope J Hallett, James M Schumacher, et al.American Journal of Physiology. Cell Physiology|December 1, 2006
Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolinTeresia M Osborn, Claes Dahlgren, John H Hartwig, et al.Arthritis Research & Therapy|September 30, 2008
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritisTeresia M Osborn, Margareta Verdrengh, Thomas P Stossel, et al.The Journal of Cell Biology|December 7, 2007
Structural basis of filamin A functionsFumihiko Nakamura, Teresia M Osborn, Christopher A Hartemink, et al.Plos One|March 19, 2009
Molecular basis of filamin A-FilGAP interaction and its impairment in congenital disorders associated with filamin A mutationsFumihiko Nakamura, Outi Heikkinen, Olli T Pentikäinen, et al.Cell Stem Cell|March 4, 2015
Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's diseasePenelope J Hallett, Michela Deleidi, Arnar Astradsson, et al.Experimental Neurology|June 8, 2014
ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stressJesse R McLean, Gaynor A Smith, Emily M Rocha, et al.Stem Cell Reports|January 1, 2019
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S MutationJoanna A Korecka, Sebastien Talbot, Teresia M Osborn, et al.Pageof 1